Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Yujen Wang (NPI 1427048693)

Field	Value
Entity Type	Individual
Organization	Yujen Wang
Address	1518 E Barnett Rd
City	Medford
State	OR
ZIP	97504
Taxonomy	Ophthalmology Physician
NPI Enumerated	October 27, 2005

Payer Source	Total Paid
Medicare	$5.4M
Medicaid	$0

Key Findings

This provider’s Medicare revenue is highly concentrated: the top three Medicare codes (J2777, J0178, 67028) together account for 84.0% of total Medicare revenue. Individually those codes are listed as J2777 $2.8M (52.6% of this provider's total Medicare revenue), J0178 $1.4M (26.2%), and 67028 $284.8K (5.3%), indicating that a small set of services drives the vast majority of billings. This concentration implies material dependence on a narrow set of clinical services and associated drug reimbursement.

The code mix points to a retina-focused ophthalmology operation with high volumes of intravitreal injections and in‑office retinal imaging. J2777 (faricimab) and J0178 (aflibercept) are the two largest revenue drivers and are complemented by frequent use of diagnostic imaging codes such as 92235, 92134, and 92250, suggesting the practice performs both injection therapy and the imaging needed for neovascular and macular disease management. Lower-volume surgical codes (e.g., 67042) appear, but revenue is dominated by medical retinal care and device/drug administration.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $5.4M while there is no Medicaid billing on file. With no recorded Medicaid activity, operational and revenue planning will be driven by Medicare reimbursement dynamics rather than dual-payer mix considerations. Analysts should treat this as a Medicare-centric practice when modeling reimbursement sensitivity or access to non‑Medicare populations.

The provider is a national outlier on several high-impact codes, signaling dominant penetration in specific services. J2777 ranks #20 of 2039 providers nationally (99th percentile; extreme outlier), identifying this clinician as an exceptionally high-volume user of faricimab compared with peers, while J0178 ranks #511 of 3204 (84th percentile; typical, unremarkable volume). In addition, 67028 ranks #88 of 4255 (98th percentile; notably above typical national volume), reinforcing the provider’s unusually large volume of isolated intravitreal injection procedures.

Routine outpatient evaluation and management volumes are also unusually high, consistent with a large active patient panel requiring frequent follow-up. 92014 shows 2.3K claims and $202.4K revenue (3.7% of total Medicare revenue) and ranks #162 of 35415 (100th percentile; extreme outlier), while 99214 has 1.2K claims and $111.4K revenue (2.1%) and ranks #6971 of 479517 (99th percentile; extreme outlier). These E/M volumes indicate substantial ongoing medical management and follow-up care tied to the retinal treatment workload.

Diagnostic and imaging services are a material and above‑typical part of the practice’s footprint, supporting the injection-heavy service line. 92235 (1.3K claims, $129.7K revenue) ranks #12 of 2192 (99th percentile; extreme outlier), 92134 (3K claims, $88.5K revenue) ranks #431 of 26868 (98th percentile; extreme outlier), and 92250 (1.4K claims, $36.3K revenue) ranks #98 of 25087 (100th percentile; extreme outlier). The concentration of high national ranks across multiple retinal imaging codes indicates substantial in‑office diagnostic capacity and throughput.

The provider has a long tenure in the Medicare program, with NPI enumeration dated 2005-10-27 (~21 years ago), which is consistent with an established referral base and sustained service patterns. Longitudinal presence combined with exceptionally high volumes for select retinal drugs and imaging codes suggests operational scale and entrenched clinical workflows. Analysts should consider tenure when assessing network relationships, referral stability, and historical billing trends.

Because a majority of revenue is concentrated in drug administration and a few procedure codes, the practice has elevated exposure to changes in drug utilization patterns and reimbursement for those codes. Given that J2777 alone represents $2.8M (52.6% of Medicare revenue) and the top three codes total 84.0% of Medicare revenue, shifts in access to faricimab or aflibercept, changes in reimbursement, or formulary dynamics could materially affect revenue. Payer negotiations, utilization management, or protocol changes around anti‑VEGF therapy would therefore have outsized financial impact for this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	98,040	$30	$2.8M
J0178	Injection, aflibercept, 1 mg	2,060	$690	$1.4M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,130	$90	$284.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,270	$90	$202.4K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	1,310	$100	$129.7K
J2778	Injection, ranibizumab, 0.1 mg	610	$180	$112.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,210	$90	$111.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,950	$30	$88.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	500	$150	$75K
J7999	Compounded drug, not otherwise classified	720	$70	$51.9K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Yujen Wang — 8 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	6	60	840	$680	$623.7K
J2777	1	30	10,050	$30	$527.6K
J2778	5	20	400	$180	$87.8K
67028	1	70	580	$90	$72.3K
J7312	2	10	300	$150	$47.7K
67042	4	10	20	$1,100	$27.5K
J7999	6	50	270	$70	$23.4K
92014	1	440	110	$80	$16K
66821	140	160	40	$230	$15.4K
92235	1	30	60	$100	$11.1K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Yujen Wang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Oregon Retina Specialists, LLC	OR	Ophthalmology Physician	$0	$3.8M
Joshua Carlson	UT	Retina Specialist (Ophthalmology) Physician	$2.6M	$0

Nearby Providers

Other providers in the same ZIP code as Yujen Wang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Asante	OR	General Acute Care Hospital	$0	$29.7M
Addictions Recovery Center, Inc.	OR	Substance Abuse Rehabilitation Facility	$0	$29.2M
Asante Physician Partners	OR	Family Medicine Physician	$0	$27.2M
Mercy Flights Incorporated	OR	Ambulance	$3.6M	$19.4M
Providence Health & Services - Oregon	OR	General Acute Care Hospital	$0	$20.9M
Crc Health Oregon, LLC	OR	Methadone Clinic	$193K	$13M
James Kolby Robinson, Dmd	OR	Pediatric Dentistry	$0	$11.6M
Valley Immediate Care, LLC	OR	Urgent Care Clinic/Center	$0	$9.4M
Lincare Inc	OR	Durable Medical Equipment & Medical Supplies	$0	$7.1M
Southern Oregon Pediatrics, LLP	OR	Pediatric Hospice and Palliative Medicine Physician	$0	$6.5M

Yujen Wang — Billing Profile & Reimbursement Data

Sign up for Yujen Wang — Billing Profile & Reimbursement Data policy alerts

Yujen Wang — Billing Profile & Reimbursement Data

Sign up for Yujen Wang — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References